Oxidative stress in patients with Friedreich ataxia
- PMID: 11113228
- DOI: 10.1212/wnl.55.11.1719
Oxidative stress in patients with Friedreich ataxia
Abstract
Increased generation of reactive oxygen species may underlie the pathophysiology of Friedreich ataxia (FRDA). The authors measured concentrations of 8-hydroxy-2'-deoxyguanosine (8OH2'dG), a marker of oxidative DNA damage, in urine and of dihydroxybenzoic acid (DHBA), a marker of hydroxyl radical attack, in plasma of 33 patients with FRDA. They found a 2.6-fold increase in normalized urinary 8OH2'dG but no change in plasma DHBA as compared with controls. Oral treatment with 5 mg/kg/day of the antioxidant idebenone for 8 weeks significantly decreased urinary 8OH2'dG concentrations, indicating that 8OH2'dG may be useful in monitoring therapeutic interventions in patients with FRDA.-1721
Comment in
-
A therapeutic target and biomarker in Friedreich's ataxia.Neurology. 2000 Dec 12;55(11):1600-1. doi: 10.1212/wnl.55.11.1600. Neurology. 2000. PMID: 11113210 No abstract available.
Similar articles
-
Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: a randomised, placebo-controlled trial.Lancet Neurol. 2007 Oct;6(10):878-86. doi: 10.1016/S1474-4422(07)70220-X. Lancet Neurol. 2007. PMID: 17826341 Clinical Trial.
-
Increased oxidative damage to DNA in ALS patients.Free Radic Biol Med. 2000 Oct 1;29(7):652-8. doi: 10.1016/s0891-5849(00)00349-x. Free Radic Biol Med. 2000. PMID: 11033417
-
A carbon column-based liquid chromatography electrochemical approach to routine 8-hydroxy-2'-deoxyguanosine measurements in urine and other biologic matrices: a one-year evaluation of methods.Free Radic Biol Med. 1999 Sep;27(5-6):647-66. doi: 10.1016/s0891-5849(99)00113-6. Free Radic Biol Med. 1999. PMID: 10490286
-
Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.J Neurol Sci. 2005 Jun 15;233(1-2):145-62. doi: 10.1016/j.jns.2005.03.012. J Neurol Sci. 2005. PMID: 15896810 Review.
-
Friedreich Ataxia: From the Eye of a Molecular Biologist.Neurologist. 2015 Sep;20(3):51-5. doi: 10.1097/NRL.0000000000000054. Neurologist. 2015. PMID: 26375377 Review.
Cited by
-
Redox processes in neurodegenerative disease involving reactive oxygen species.Curr Neuropharmacol. 2012 Dec;10(4):289-302. doi: 10.2174/157015912804143487. Curr Neuropharmacol. 2012. PMID: 23730253 Free PMC article.
-
Time-resolved functional analysis of acute impairment of frataxin expression in an inducible cell model of Friedreich ataxia.Biol Open. 2016 May 15;5(5):654-61. doi: 10.1242/bio.017004. Biol Open. 2016. PMID: 27106929 Free PMC article.
-
Neurodegeneration in Friedreich's ataxia: from defective frataxin to oxidative stress.Oxid Med Cell Longev. 2013;2013:487534. doi: 10.1155/2013/487534. Epub 2013 Jul 9. Oxid Med Cell Longev. 2013. PMID: 23936609 Free PMC article. Review.
-
Effects of Fe2+/Fe3+ Binding to Human Frataxin and Its D122Y Variant, as Revealed by Site-Directed Spin Labeling (SDSL) EPR Complemented by Fluorescence and Circular Dichroism Spectroscopies.Int J Mol Sci. 2020 Dec 17;21(24):9619. doi: 10.3390/ijms21249619. Int J Mol Sci. 2020. PMID: 33348670 Free PMC article.
-
The Role of NRF2 in Trinucleotide Repeat Expansion Disorders.Antioxidants (Basel). 2024 May 26;13(6):649. doi: 10.3390/antiox13060649. Antioxidants (Basel). 2024. PMID: 38929088 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical